Skip to main content
OpenTrials
Completed

NCT Number: NCT00807456

Study to Evaluate an Implant With a Sloped Top in Patients With a Sloped Jaw Bone

The study aims to evaluate maintenance of lingual/palatinal marginal bone with the (ASTRA TECH Implant System) OsseoSpeed™ Profile implant in sites where the alveolar crest anatomy is sloped in a lingual to buccal direction.

The hypothesis is that the sloped marginal contour of the implant will help preserve the lingual/palatinal marginal bone.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Edentulism

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Medizinische Hochschule Hannover, Hanover, Germany

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Provision of informed consent
  • Aged 18-75 years at enrolment
  • A lingual-buccal difference in bone height between 2.0-5.0 mm at the implant site
  • History of edentulism in the study area of at least 3 months
  • Presence of alveolar bone crest dimensions judged by the investigator to allow ≥1mm of bone circumferential to the implant after implant placement.
  • In need for a single implant replacing a missing tooth in any location with an adjacent natural tooth mesially, and an adjacent natural tooth or edentulous space distally to the planned implant position (i.e. no existing or planned implant adjacent to the planned study implant position)
  • Deemed by the investigator as likely to present an initially stable implant situation

Exclusion criteria

  • Uncontrolled pathological processes in the oral cavity
  • Known or suspected current malignancy
  • History of radiation therapy in the head and neck region
  • History of chemotherapy within 5 years prior to surgery
  • Systemic or local disease or condition that would compromise post-operative healing and/or osseointegration
  • Uncontrolled diabetes mellitus
  • Corticosteroids or any other medication that would compromise post-operative healing and/or osseointegration
  • Smoking more than 10 cigarettes per day
  • Present alcohol and/or drug abuse
  • Current need for bone grafting in the planned implant area
  • Previous enrolment in the present study
  • Simultaneous participation in another clinical study or participation in a clinical study during the last 6 months
  • Involvement in the planning and conduct of the study (applies to both Sponsor staff or staff at the study site)
  • Unlikely to be able to comply with study procedures, as judged by the investigator

Treatment and study plan

ASTRA TECH Implant System, OsseoSpeed™

Device

ASTRA TECH Implant System, OsseoSpeed™ Profile implants: Ø4.5, 5.0, 5.0S mm in lengths of 9, 11, 13, 15mm.

Primary outcomes

  1. Bone Level Changes at the Lingual Aspect From Implant Placement (Baseline) to Re-entry 16 Weeks After Implant Placement

    Time frame: At baseline and 16 weeks

    Clinical measurements after implant installation and after 16 weeks to determine bone levels at the buccal and lingual aspects in relation to a fixed landmark on the implant, i.e. the interface between the micro-threaded part and the shoulder at the marginal portion of the implants.The assessments were made using a periodontal probe and distances were measured to the nearest 0.5 mm. Negative value denotes loss of bone.

Secondary outcomes

  1. Implant Survival Rate

    Time frame: 21 weeks, 12 months, 24 months and 36 months post implant placement.

    The survival rate for individual implants was evaluated at each visit. Any removed implant was considered an implant loss, regardless of reason for removal.

  2. Marginal Bone Level (MBL) Change From Implant Placement Presented on Implant Level

    Time frame: Baseline and 16 weeks, 21 weeks, 12 months, and 36 months post implant placement

    MBL alteration assessed by measuring the distance from the implant reference point to the most conical bone-to-implant contact on the mesial and distal side of the implant. The mean of all values for one subject was calculated and used for analysis.

  3. Condition of Peri-Implant Tissues Measured Through Bleeding on Probing (BoP)

    Time frame: 21 weeks, 12 months, 24 months, and 36 months post implant placement

    BoP was assessed by recording bleeding after probing at the mesial, distal, buccal, and palatal surfaces of the implant site.

  4. Condition of Peri-implant Tissues Measured by Average Change in Probing Pocket Depth (PPD) From Permanent Restoration

    Time frame: Baseline and 12 months, 24 months, and 36 months post implant placement

    PPD was measured using a regular peridontal probe from the gingival margin to nearest whole millimeter. The average PPD change from permanent restoration is presented on implant level.

  5. Condition of Peri-implant Tissues Measured by Average Change in Clinical Attachment Level (CAL) From Permanent Restoration

    Time frame: Baseline and 12 months, 24 months, and 36 months post implant placement

    CAL was measure with a probe from the crown margin (the interface between the abutment) to the crown at the mesial, buccal, distal, and lingual aspects of the implant. The average CAL change from permanent restoration is presented on implant level.

Sponsors and collaborators

Lead sponsor

Dentsply Sirona Implants and Consumables

Industry

Registry information

Official study title

A Prospective, Open, Single Arm, Multi-center Study to Evaluate Maintenance of Lingual Bone in Healed Ridges With the ASTRA TECH Implant System, OsseoSpeed™ Profile Implant. A 3-year Follow-up Study

Important dates

Study start
2008
Primary completion
2013
Study completion
2013
First posted
Dec 12, 2008
Registry last updated
Nov 17, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.